Overview
The management of ovarian, endometrial, and cervical cancers is rapidly evolving with the emergence of biomarker-driven therapies, novel drug classes, and multidisciplinary care strategies. Clinicians must navigate complex treatment decisions, apply trial findings to real-world settings, and individualize care for diverse patient populations—highlighting ongoing challenges in this field.
The 17th Annual International Symposium on Gynecologic Malignancies is a one-day educational
event designed to address these challenges through focused, expert-led
discussions. Held in an interactive format, the program features dynamic
presentations, tumor boards, and panel sessions covering topics such as
precision oncology in endometrial cancer, novel ADCs in cervical cancer, and
updates in ovarian cancer maintenance, immunotherapy, and emerging targets.
This format fosters dialogue between faculty and participants, equipping
clinicians with practical tools to enhance patient care.
Learning Objectives
- Integrate germline and somatic testing results to guide personalized treatment selection and risk assessment in gynecologic cancers.
- Assess current and emerging clinical data on the efficacy, safety, and optimal use of established and novel therapies for gynecologic cancers.
- Apply recent clinical trial findings and evolving treatment strategies, including targeted and immunotherapy approaches, to real-world patient care.
- Implement evidence-based strategies to prevent, monitor, and manage treatment-related adverse effects in patients with gynecologic cancers.
Program Co-Chairs
Ritu Salani, MD, MBA; Kathleen Moore, MD
To view full profile, click on the Program Co-Chairs tab above.
